This is the major version 2025.2 of its product line for ANSA, EPILYSIS, META, KOMVOS, SPDRM, FATIQ, ANSERS and RETOMO..

This new investment supports BETA’s continued momentum certifying, producing and deploying all-electric aircraft and infrastructure, serving both commercial and military customers across cargo, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

A major stride in battery science has unlocked a pathway that could accelerate solid-state innovation. A team, co-led by engineers at the University of California, San Diego, has unveiled a strategy ...

Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...

Read Seven Days’ November 5, 2025, cover story on Beta here. Vermont electric aviation startup Beta Technologies raked in more than $1 billion on Tuesday as it debuted on the New York Stock Exchange ...

In a change of pace, one company operating in the aerospace sector is expected to make its market debut today. Here’s what you need to know about Beta Technologies and its initial public offering: ...

The price of BETA shares has decreased $0.63 since the market last closed. This is a 2.13% drop. Closed at $28.89. The stock has since risen $0.36 in after-hours trading. Beta Technologies, Inc.

Autoantibodies for type 1 diabetes are markers of the immune system’s attack on beta cells. Testing for these autoantibodies – GAD, IA-2, IAA, ZnT8, and ICA – can help with monitoring and preparing ...

Beta Technologies has a partnership with GE Aerospace IPO market reopens for high-growth startups Beta's aircraft used by US military and FAA Sept 29 (Reuters) - Electric aircraft maker Beta ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...